Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Beyondspring (BYSI)
:BYSI
Holding BYSI?
Track your performance easily
BYSI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.82 - $4.00
Previous CloseN/A
Volume3.10K
Average Volume (3M)26.84K
Market Cap
$69.32M
Enterprise Value$87.01M
Total Cash (Recent Filing)$11.69M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.41
Next Earnings
Apr 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding40,300,350
10 Day Avg. Volume14,645
30 Day Avg. Volume26,835
Standard Deviation0.51
R-Squared0.00075
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)38.34
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.26
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit49.69
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Beyondspring News
PremiumCompany Announcements
BeyondSpring Inc. Reports Mid-Year Financials
PremiumCompany Announcements
SEED and Eisai Partner on Groundbreaking Biotech Research
Options Prices
Currently, No data available
---
Ownership Overview
12.30%
Insiders
0.08% Mutual Funds
12.41% Other Institutional Investors
75.08% Public Companies and
Individual Investors
BYSI FAQ
What was Beyondspring’s price range in the past 12 months?
Beyondspring lowest stock price was $0.82 and its highest was $4.00 in the past 12 months.
What is Beyondspring’s market cap?
Beyondspring’s market cap is $69.32M.
When is Beyondspring’s upcoming earnings report date?
Beyondspring’s upcoming earnings report date is Apr 30, 2025 which is in 98 days.
How were Beyondspring’s earnings last quarter?
Beyondspring released its earnings results on Aug 29, 2024. The company reported -$0.186 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.186.
Is Beyondspring overvalued?
According to Wall Street analysts Beyondspring’s price is currently Overvalued.
Does Beyondspring pay dividends?
Beyondspring does not currently pay dividends.
What is Beyondspring’s EPS estimate?
Beyondspring’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beyondspring have?
Beyondspring has 40,300,350 shares outstanding.
What happened to Beyondspring’s price movement after its last earnings report?
Beyondspring reported an EPS of -$0.186 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.515%.
Which hedge fund is a major shareholder of Beyondspring?
Currently, no hedge funds are holding shares in BYSI
---
Beyondspring Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
101.87%
12-Months-Change
Fundamentals
Return on Equity
78.44%
Trailing 12-Months
Asset Growth
-36.44%
Trailing 12-Months
Company Description
Beyondspring
BeyondSpring, Inc. is a clinical stage company, which engages in the development of cancer therapies. It focuses on non-small cell lung cancer, neutropenia prevention, and plinabulin and nivolumab. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.
---
Technical Analysis
―
CASI Pharmaceuticals
―
Kazia Therapeutics
―
Eloxx Pharmaceuticals
―
Fennec Pharmaceuticals
―
---